Imogam Market Report 2026

Imogam Market Overview

• The Imogam market growth in the historic period has been driven by high rabies mortality rates, limited early accessvaccines • Market expansion is supported by increasing animal bite incidents, expansion of rabies awareness campaigns • Growth Driver: Rising Incidence Of Animal Bites Driving Market Growth • North America was the largest region in 2025.

What Is Covered Under Imogam Market?

Imogam is a brand name for a human rabies immune globulin (HRIG) product. It is part of post-exposure prophylaxis (PEP) to prevent rabies infection after exposure to the rabies virus. The product provides passive immunity by supplying antibodies against rabies. The main patient demographics of imogam are pediatric patients, adult patients, and high-risk groups. Pediatric patients refer to children who are at risk of contracting rabies due to animal bites or scratches. Treatment for pediatric patients often involves age-specific dosages of rabies vaccines and rabies immune globulin such as imogam to prevent infection. It is distributed through various channels such as hospitals, dpecialty clinics, online pharmacies, and pharmacies for applications such as post-exposure prophylaxis and pre-exposure prophylaxis.

What Is The Imogam Market Growth Forecast?

The growth in the forecast period can be attributed to increasing animal bite incidents, expansion of rabies awareness campaigns, growth in emergency healthcare infrastructure, improved access to immunoglobulins, rising government investment in zoonotic control. Major trends in the forecast period include continued demand for rabies post exposure prophylaxis, expansion of passive immunization use, rising focus on zoonotic disease prevention, growth in emergency immunoglobulin administration, strengthening public health preparedness.

Global Imogam Market Segmentation

1) By Patient Demographics: Pediatric Patients, Adult Patients, High-Risk Groups 2) By Application: Post-Exposure Prophylaxis, Pre-Exposure Prophylaxis 3) By Distribution Channel: Hospitals, Specialty Clinics, Online Pharmacies, Pharmacies

What Are The Drivers Of The Imogam Market?

The increasing incidence of animal bites is expected to propel the growth of the imogam market going forward. Animal bites refer to incidents where individuals are bitten by animals, leading to injuries that may require medical attention. The increase in the number of animal bites is due to factors such as a growing pet population, inadequate animal control, and increased human-animal interactions. Imogam is used for immediate post-exposure prophylaxis in animal bite victims to provide passive immunity against rabies until the rabies vaccine takes effect. For instance, in September 2024, according to an article published by Dogster, a US-based bimonthly magazine and website, in 2023, there were 6,000 dog bite incidents. Additionally, the fatalities from dog bites increased fivefold, rising from 5 in 2022 to 15 in 2023. Therefore, the increasing incidence of animal bites is driving the growth of the imogam industry. The rising international travel is expected to propel the growth of the imogam market going forward. A rise in international travel indicates increasing global mobility and tourism due to factors such as eased restrictions, improved connectivity, and growing disposable incomes. Increased international travel heightened exposure to rabies-endemic regions, boosting demand for imogam as a critical post-exposure prophylaxis. For instance, in May 2024, according to the Office for National Statistics, a UK-based national statistical institute and largest independent producer of official statistics, the number of overseas visitors to the UK rose from 31.2 million in 2022 to 38.0 million in 2023. Therefore, the increasing occurrence of animal bites is fueling the growth of the imogam industry. The expansion of healthcare infrastructure is expected to propel the growth of the imogam market going forward. Healthcare infrastructure refers to the physical and organizational structures, facilities, resources, and systems necessary for delivering healthcare services to a population. The aging global population, the increase in chronic diseases, and technological advancements drive the expansion of healthcare infrastructure. Robust healthcare infrastructure is crucial for Imogam Rabies-HT's progress, ensuring cold chain maintenance, timely administration, and accessibility in rabies post-exposure prophylaxis. For instance, in May 2024, according to a report published by Office For National Statistics, a UK-based government agency, total healthcare expenditure rose 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, expanding healthcare infrastructure is driving the growth of the imogam industry.

Key Players In The Global Imogam Market

Major companies operating in the imogam market are Sanofi SA

Regional Insights

North America was the largest region in the imogam market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Imogam Market?

The imogam market consists of sales of imogam rabies-HT 150 IU/mL vial, and imogam injection. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Imogam Market Report 2026?

The imogam market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the imogam industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.